Yang, Lixian
An, Mengyang
song, Heng
Zhang, Xuan
Wang, Meiqi
Yang, Liu
Wang, Xinle
Yang, Hua
Hong, Xinyue
Song, Zhenchuan
Funding for this research was provided by:
Natural Science Foundation of Hebei Province (H2020206365)
S&T Program of Hebei Province (236Z7719G)
Innovative Drugs Post-market Clinical Research Special Program (WKZX2024CX103205)
Article History
Received: 8 January 2025
Accepted: 29 November 2025
First Online: 9 December 2025
Declarations
:
: The present study was approved by the Medical Ethics Committee of the Fourth Hospital of Hebei Medical University (No. 2023KY032), and was carried out in accordance with the Declaration of Helsinki.
: All authors have consented to the publication of this article.
: The authors declare no competing interests.